Rotating shift work and risk for prostate cancer

There have been suggestions in the past that people who work shifts, cycling between day and night work, may be at higher risk for various cancers than people who do regular daytime work. … READ MORE …

A rising incidence of intermediate- and higher-risk prostate cancer … but what does this mean?

According to another paper to be presented at the Genitourinary Cancers Symposium in Orlando, Florida, that started this morning, there was a 6 percent increase in the proportion of patients being diagnosed with intermediate- or higher-risk prostate cancers between 2011 and 2013. … READ MORE …

From Amsterdam yesterday: European perspectives on the PSA screening issue

A report on the Medscape Oncology web site, published late yesterday, discusses two presentations given yesterday at the European Cancer Conference 2013, currently being held in Amsterdam. … READ MORE …

Hyping the risk for prostate cancer … to what end?

According to a media release issued by Cancer Research UK a few days ago, “Boys born in 2015 will have almost three times the risk of being diagnosed with prostate cancer at some point during their lives than those born in 1990.” … READ MORE …

Estimated prostate cancer cases/deaths in USA in 2013

According to the newly published report, “Cancer statistics, 2013,” now available in the journal CA: A Cancer Journal for Clinicians, prostate cancer will become the most commonly diagnosed cancer of any type in the USA this year. … READ MORE …

Rare variants of adenocarcinoma of the prostate: a 25-year analysis of incidence and mortality

The vast majority of prostate cancers are adenocarcinomas of the prostate, i.e., cancers that start in the epithelial cells of the prostate gland. Most of these adenocarcinomas have a well-defined, “normal” cancer histology. However, there are five categories of rare adenocarcinoma, with differing levels of risk. … READ MORE …

In Denmark … PSA-based testing for risk shows no significant impact on prostate cancer mortality (yet)

The question whether widespread use of the PSA test to test for risk of prostate cancer has a significant impact on prostate cancer-specific mortality continues to be highly controversial and to engender strong emotions among many medical professionals, patients, and prostate cancer advocates. … READ MORE …